Clinical study on the treatment of acute pancreatitis with external application of Yi-Dan Therapy based on the method of "stagnation requiring dispersion"

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003477

Enrollment

Unknown

Registered

2020-07-09

Start date

2020-08-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatitis

Interventions

Control group:Basic treatment

experimental group:External application of Yi-Dan ointment+Basic treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-75 years; (2) meet the diagnostic criteria of AP; (3) sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; (2) patients with mental disorders who can not cooperate with them; (3) subjects who are participating in clinical trials of other drugs at the same time or are using drugs with similar therapeutic effects as the experimental drugs; (4) patients with skin damage and skin diseases in abdomen; (5) pregnant and lactating women; (6) patients who have been hospitalized with mental disorders Know Chinese herbal medicine allergy.

Design outcomes

Primary

Measure	Time frame
Total efficiency;	—

Secondary

Measure	Time frame
leukocyte;PCT;classification of CT;IL-10;IL-6;VAS score;Symptom score;TNF-a;CRP;	—

Countries

China

Contacts

Public ContactCheng Hongjie

Fangshan Hospital, Beijing University of Chinese Medicine

chenghongjie1971@163.com+86 13911721636

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026